Synta Pharmaceuticals Corp.
USPTO PatentsView assignee record - 31 granted patents across 11 technology areas, recorded in grant years 2015–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Synta ranks #10,195 of 49,997 tracked US assignees by granted-patent volume, with 31 patents across 11 technology areas.
- #10,195
- of 49,997 US assignees by volume
- 48th percentile
- by Innovation Score (34.7/100)
- 12.8
- avg claims per patent
- -93%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R10195 · US Corporation #10,195 · 31 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-SMALL 31 grants
- UPPER-Q #10,195/49,997
- PHOTO-FINISH Starmark Pet Products
- CPC-FOCUS A61P · 11 areas
- INNOV-THIN 34.7/100
- CLAIMS-RICH 12.8 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -93% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Starmark Pet Products, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Synta’s 34.7 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Synta
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- White Swell Medical · near
White Swell Medical · near
35 score
- Adams Mfg · near
Adams Mfg · near
35 score
- Nagrastar · near
Nagrastar · near
35 score
- SiFotonics · near
SiFotonics · near
35 score
- Synta Pharmaceuticals · this assignee
Synta Pharmaceuticals · this assignee
35 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Synta's Innovation Score is 34.7/100 (48th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Synta?
Each dot is one of Synta’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Synta’s own 12.8 claims/patent is ABOVE the 11.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Synta's grants concentrate
Synta Pharmaceuticals Corp. is a focused PatentsView assignee: 11 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2015 (22 grants) versus a trough of 1 in 2019. By volume, Synta sits between Starmark Pet Products, Inc. and Tech 21 Licensing Limited.
Synta's three-year grant acceleration
Synta Pharmaceuticals Corp. shows 1 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Synta's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Starmark Pet Prod…
Starmark Pet Products, Inc.
31 patents
- Stasher
Stasher, Inc.
31 patents
- Sunasic
SunASIC Technologies, Inc.
31 patents
- Sustainable Energ…
Sustainable Energy Solutions, Inc.
31 patents
- System General
System General Corp.
31 patents
- TA Instruments-wa…
TA Instruments-Waters LLC
31 patents
- Taipei Veterans G…
Taipei Veterans General Hospital
31 patents
- Tech 21 Licensing
Tech 21 Licensing Limited
31 patents
- Synta Pharmaceuti… ◀
Synta Pharmaceuticals Corp.
31 patents
What this shows Synta holds 31 patents at rank #10,195, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Synta
By rank, the assignees closest to #10,195 in granted patent volume.
- Starmark Pet Products, Inc. #10,191 · 31 patents
- Stasher, Inc. #10,192 · 31 patents
- SunASIC Technologies, Inc. #10,193 · 31 patents
- Sustainable Energy Solutions, Inc. #10,194 · 31 patents
- System General Corp. #10,196 · 31 patents
- TA Instruments-Waters LLC #10,197 · 31 patents
- Taipei Veterans General Hospital #10,198 · 31 patents
- Tech 21 Licensing Limited #10,199 · 31 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Synta's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Synta, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Synta ranks #634 of 6,058 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (35 here).
Synta's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
35 48th percentile higher than 48% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 22 | 71.0% |
| 2016 | 3 | 9.7% |
| 2017 | 3 | 9.7% |
| 2019 | 1 | 3.2% |
| 2021 | 1 | 3.2% |
| 2022 | 1 | 3.2% |
Which technologies does Synta Pharmaceuticals Corp. patent most?
Top 11 of 11 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Synta Pharmaceuticals Corp.'s patent record in context - here's where to go next.
- Synta Pharmaceuticals Corp.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #10,195 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Synta Pharmaceuticals Corp. against Starmark Pet Products, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 34.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.